Andriy Onufriyenko/Getty Images
By
Edward Graham,Managing Editor, Nextgov/FCW
By
Edward Graham
White House’s new high-risk life sciences policy calls for monitoring AI dangers
“The White House Office of Science and Technology Policy (OSTP) will convene an interagency group to monitor advancements at the intersection of biological sciences and artificial intelligence, including in silico life sciences research,” the guidance says.
TL;DRAI
Trump administration halts federal funding for dangerous gain-of-function research and establishes White House oversight of AI advancements in life sciences. Regulatory precedent for dual-use AI: monitoring vs bans model reshapes compliance for biotech and foundation-model R&D.
722 words~3 min read
